28 October 2009 - Dr. Edward Hodgkin elected to the Board of Directors of BIA
Biotica CEO, Dr. Edward Hodgkin, has been elected to the Board of Directors of the BioIndustry Association (BIA).
02 October 2009 - Biotica achieves preclinical proof-of-concept in nPT-CLN asthma programme
nPT-CLN compounds for inhaled use in asthma show high local potency against calcineurin, but minimal systemic exposure when given by inhalation, orally or IV.
11 September 2009 - Biotica alliance with GSK shortlisted for prestigious Scrip Award
The alliance, announced in January 2009, covers Biotica's nPT-ery programme of novel erythromycin analogues for use in anti-inflammatory indications
25 June 2009 - Biotica adds nPT-CyP, a series of polyketide cyclophilin inhibitors for HCV, to its pipeline
Biotica expands its development-track pipeline with nPT-CyP, a non-cyclosporin cyclophilin inhibitor for HCV
26 May 2009 - Dr Alan Lewis joins Biotica Board
Biotica today announced the appointment of Dr Alan Lewis as a Non-Executive Director
Biotica CEO, Dr. Edward Hodgkin, has been elected to the Board of Directors of the BioIndustry Association (BIA).
02 October 2009 - Biotica achieves preclinical proof-of-concept in nPT-CLN asthma programme
nPT-CLN compounds for inhaled use in asthma show high local potency against calcineurin, but minimal systemic exposure when given by inhalation, orally or IV.
11 September 2009 - Biotica alliance with GSK shortlisted for prestigious Scrip Award
The alliance, announced in January 2009, covers Biotica's nPT-ery programme of novel erythromycin analogues for use in anti-inflammatory indications
25 June 2009 - Biotica adds nPT-CyP, a series of polyketide cyclophilin inhibitors for HCV, to its pipeline
Biotica expands its development-track pipeline with nPT-CyP, a non-cyclosporin cyclophilin inhibitor for HCV
26 May 2009 - Dr Alan Lewis joins Biotica Board
Biotica today announced the appointment of Dr Alan Lewis as a Non-Executive Director